Search Within

Larry Norton

Formats
  1. Journal Article (409)
  2. Meeting Abstract (295)
  3. Book Section (21)
  4. Conference Paper (16)
  5. Editorial (8)
  6. Guidelines (3)
  7. Correspondence (2)
  8. Miscellaneous (2)
  9. Book Whole (1)
  10. Review (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (758)
  2. Breast Medicine Service (758)
  3. Department of Medicine (758)
  4. Solid Tumor Oncology Division (758)
  5. Survivorship Research (392)
  6. GSK Faculty (222)

More Groups

People
  1. Clifford Hudis (293)
  2. Edi Brogi (114)
  3. Andrew Seidman (99)
  4. Sujata Patil (97)
  5. Mark Robson (89)
  6. Hannah Wen (82)

More People

Years
  1. 2025 (5)
  2. 2024 (19)
  3. 2023 (18)
  4. 2022 (16)
  5. 2021 (13)
  6. 2020 (26)

More Years

Publications
  1. Journal of Clinical Oncology (155)
  2. Cancer Research (79)
  3. Breast Cancer Research and Treatment (48)
  4. Clinical Cancer Research (30)
  5. Laboratory Investigation (26)
  6. Modern Pathology (24)

More Publications

Publishers
  1. American Society of Clinical Oncology (159)
  2. American Association for Cancer Research (124)
  3. Nature Publishing Group (75)
  4. Springer (61)
  5. Oxford University Press (50)
  6. Elsevier Inc. (48)

More Publishers

Results (758)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Antitumor activity of paclitaxel in combination with anti-growth factor receptor monoclonal antibodies in breast cancer xenografts
    Meeting Abstract

    Baselga, J.; Norton, L.; Coplan, K.; Shalaby, R.; Mendelsohn, J.
    Proceedings of the American Association for Cancer Research Annual Meeting (1994)

    Fulltext@MSK | Save
  • Taxol in combination with cyclophosphamide and GCSF, a novel peripheral blood progenitor cell mobilizing regimen
    Meeting Abstract

    Fennelly, D.; Bengala, C.; Schneider, J.; Hakes, T.; Spriggs, D.; Reich, L.; Yao, T. J.; Shapiro, F.; Norton, L.; Moore, M. A. S.; more...
    Proceedings of the American Association for Cancer Research Annual Meeting (1994)

    Fulltext@MSK | Save
  • Treatment of advanced ovarian cancer (AOC) with high-dose (HD) carboplatin (C) and escalating-dose taxol (TXL) with cyclophosphamide (CTX)/TXL-primed peripheral blood progenitor cells (PBP) as hematological support (HS): A phase I study
    Meeting Abstract

    Fennelly, D.; Schneider, J.; Hakes, T.; Crown, J.; Bengala, C.; Reich, L.; Moore, M.; Gulati, S.; Shapiro, F.; Barakat, R.; more...
    Gynecologic Oncology (1994)

    Fulltext@MSK | Save
  • Ongoing phase II study of intravenous recombinant human anti-p185 HER2 monoclonal antibody 4D5 (MAb 4D5) in patients with stage IV breast cancer overexpressing HER2
    Meeting Abstract

    Baselga, J.; Tripathy, D.; Mendelsohn, J.; Benz, C.; Rosen, P. P.; Henderson, I. C.; Twaddell, T.; Norton, L.
    Breast Cancer Research and Treatment (1994)

    Fulltext@MSK | Save
  • Efficacy of prolonged paclitaxel (P) infusion after failure of prior short taxane infusion: A phase II and pharmacologic study in metastatic breast cancer (MBC)
    Meeting Abstract

    Hochhauser, D.; Seidman, A. D.; Gollub, M.; Edelman, B.; Hudis, C.; Francis, P.; Auguste, L.; Bellettieri, R.; Currie, V.; Gilewski, T.; more...
    Breast Cancer Research and Treatment (1994)

    Fulltext@MSK | Save
  • Phase I trial of sequential edatrexate (ETX) followed by paclitaxel (PTX) in patients with advanced breast cancer: A design based on in-vitro (IV) synergy
    Meeting Abstract

    Fennelly, D.; Hudis, C.; Seidman, A.; Hamilton, N.; Raptis, G.; Baselga, J.; Sklarin, N.; Norton, L.
    Breast Cancer Research and Treatment (1994)

    Fulltext@MSK | Save
  • Results of sequential dose-intensive adjuvant therapy with doxorubicin and cyclophosphamide
    Meeting Abstract

    Hudis, C.; Lebwohl, D.; Yao, T. J.; Crown, J.; Gilewski, T.; Currie, V.; Raptis, G.; Seidman, A.; Fennelly, D.; Kesselman, E.; more...
    Breast Cancer Research and Treatment (1994)

    Fulltext@MSK | Save
  • Rapidly administered sequential high dose(HD) cyclophosphamide(CPA), melphalan(M), thiotepa(TT) supported by filgrastim(G) + peripheral blood progenitors(PBP) in metastatic breast cancer(MBC) patients(PTS)
    Meeting Abstract

    Raptis, G.; Crown, J.; Vahdat, L.; Fennelly, D.; Hamilton, N.; Hudis, C.; Gilewski, T.; Seidman, A.; Currie, V.; Reich, L.; more...
    Breast Cancer Research and Treatment (1994)

    Fulltext@MSK | Save
  • Anti-growth factor receptor monoclonal antibodies enhance the antitumor effects of paclitaxel in breast cancer xenografts
    Meeting Abstract

    Baselga, J.; Norton, L.; Coplan, K.; Shalaby, R.; Mendelsohn, J.
    Journal of Cellular Biochemistry (1994)

    Fulltext@MSK | Save
  • Peripheral blood progenitor cell (PBP) mobilization using Taxol (T) in combination with cyclophosphamide (C) and GCSF; Quantitation and correlation of CD34+ cell count, colony-forming-unit granulocyte-macrophage (CFU-GM), and mononuclear cell (MNC) count
    Meeting Abstract

    Fennelly, D.; Bengala, C.; Schneider, J.; Reich, L.; Norton, L.; Spriggs, D.; Moore, M. A. S.; Crown, J.
    Blood (1994)

    Fulltext@MSK | Save